Oncology Impact Fund L.P. Ubs's Net Worth
Oncology Impact Fund L.P. Ubs's net worth is estimated to be at least $4,940,941.40 as of 04/26/2024. CoreStreet's estimation of Oncology Impact Fund L.P. Ubs's net worth is based on their sale of stock and current holding of stock.
Oncology Impact Fund L.P. Ubs is Major Shareholder at Cullinan Oncology LLC. They have executed at least 11 trades of stock as per SEC Form 4 filings. Their most recent trade was for 6,425 units of CGEM stock on 09/15/2021. Their biggest sale was on 08/23/2021 when they sold 53,359 units of Cullinan Oncology LLC stock for $1,553,280.49. They typically trade 11 times per year.
Total value of insider buys:
- $0.00
Total value of insider sells:
- $4,940,941.40
Most recent insider trade:
- Sept. 15, 2021
Oncology Impact Fund L.P. Ubs's Insider Trading History
| Cullinan Oncology LLC | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 15, 2021 | Major Shareholder | 6,425 | $29.16 | Sell | $187,353.00 |
Sept. 13, 2021 | Major Shareholder | 3,595 | $29.10 | Sell | $104,614.50 |
Sept. 9, 2021 | Major Shareholder | 13,727 | $29.35 | Sell | $402,887.45 |
Sept. 7, 2021 | Major Shareholder | 25,067 | $29.04 | Sell | $727,945.68 |
Sept. 3, 2021 | Major Shareholder | 12,731 | $29.60 | Sell | $376,837.60 |
Sept. 1, 2021 | Major Shareholder | 5,714 | $29.47 | Sell | $168,391.58 |
Aug. 30, 2021 | Major Shareholder | 31,001 | $29.30 | Sell | $908,329.30 |
Aug. 27, 2021 | Major Shareholder | 13,357 | $29.09 | Sell | $388,555.13 |
Aug. 25, 2021 | Major Shareholder | 1,713 | $29.09 | Sell | $49,831.17 |
Aug. 23, 2021 | Major Shareholder | 53,359 | $29.11 | Sell | $1,553,280.49 |
Aug. 11, 2021 | Major Shareholder | 2,510 | $29.05 | Sell | $72,915.50 |